Intech Investment Management LLC Denali Therapeutics Inc. Transaction History
Intech Investment Management LLC
- $8.75 Billion
- Q3 2024
A detailed history of Intech Investment Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 29,543 shares of DNLI stock, worth $645,219. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,543Holding current value
$645,219% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
227Shares Held
119MCall Options Held
60.6KPut Options Held
48.4K-
Black Rock Inc. New York, NY13.2MShares$288 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$269 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$244 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$234 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$173 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.93B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...